334 related articles for article (PubMed ID: 8253854)
1. In vitro expression of osteoblastic markers in cells isolated from normal fetal and postnatal human bone and from bone of patients with osteogenesis imperfecta.
Mörike M; Schulz M; Brenner RE; Bushart GB; Teller WM; Vetter U
J Cell Physiol; 1993 Dec; 157(3):439-44. PubMed ID: 8253854
[TBL] [Abstract][Full Text] [Related]
2. Age-related changes in bone formation, osteoblastic cell proliferation, and differentiation during postnatal osteogenesis in human calvaria.
de Pollak C; Arnaud E; Renier D; Marie PJ
J Cell Biochem; 1997 Jan; 64(1):128-39. PubMed ID: 9015761
[TBL] [Abstract][Full Text] [Related]
3. Enzyme histochemical localisation of alkaline phosphatase activity in osteogenesis imperfecta bone and growth plate: a preliminary study.
Sarathchandra P; Cassella JP; Ali SY
Micron; 2005; 36(7-8):715-20. PubMed ID: 16182549
[TBL] [Abstract][Full Text] [Related]
4. Extracellular matrix formation by osteoblasts from patients with osteogenesis imperfecta.
Fedarko NS; Moerike M; Brenner R; Robey PG; Vetter U
J Bone Miner Res; 1992 Aug; 7(8):921-30. PubMed ID: 1442206
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of bone cells from a patient with osteogenesis imperfecta type 1b.
Puzas JE; Brand JS; Jackman KV
Bone Miner; 1986 Oct; 1(5):373-82. PubMed ID: 2849487
[TBL] [Abstract][Full Text] [Related]
6. Bone turnover and type I collagen C-telopeptide isomerization in adult osteogenesis imperfecta: associations with collagen gene mutations.
Garnero P; Schott AM; Prockop D; Chevrel G
Bone; 2009 Mar; 44(3):461-6. PubMed ID: 19071236
[TBL] [Abstract][Full Text] [Related]
7. Positive linear growth and bone responses to growth hormone treatment in children with types III and IV osteogenesis imperfecta: high predictive value of the carboxyterminal propeptide of type I procollagen.
Marini JC; Hopkins E; Glorieux FH; Chrousos GP; Reynolds JC; Gundberg CM; Reing CM
J Bone Miner Res; 2003 Feb; 18(2):237-43. PubMed ID: 12568401
[TBL] [Abstract][Full Text] [Related]
8. Effects of transforming growth factor beta on cells derived from bone and callus of patients with osteogenesis imperfecta.
Mörike M; Windsheimer E; Brenner R; Nerlich A; Bushart G; Teller W; Vetter U
J Orthop Res; 1993 Jul; 11(4):564-72. PubMed ID: 8340828
[TBL] [Abstract][Full Text] [Related]
9. Both direct and collagen-mediated signals are required for active vitamin D3-elicited differentiation of human osteoblastic cells: roles of osterix, an osteoblast-related transcription factor.
Maehata Y; Takamizawa S; Ozawa S; Kato Y; Sato S; Kubota E; Hata R
Matrix Biol; 2006 Jan; 25(1):47-58. PubMed ID: 16266799
[TBL] [Abstract][Full Text] [Related]
10. A light and electron microscopic study of osteogenesis imperfecta bone samples, with reference to collagen chemistry and clinical phenotype.
Sarathchandra P; Pope FM; Kayser MV; Ali SY
J Pathol; 2000 Nov; 192(3):385-95. PubMed ID: 11054723
[TBL] [Abstract][Full Text] [Related]
11. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts.
Jørgensen NR; Henriksen Z; Sørensen OH; Civitelli R
Steroids; 2004 Apr; 69(4):219-26. PubMed ID: 15183687
[TBL] [Abstract][Full Text] [Related]
12. Increased cartilage type II collagen degradation in patients with osteogenesis imperfecta used as a human model of bone type I collagen alterations.
Rousseau JC; Chevrel G; Schott AM; Garnero P
Bone; 2010 Apr; 46(4):897-900. PubMed ID: 20005316
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of bone formation in osteoporosis patients treated with fluoride associated with increased DNA synthesis by osteoblastic cells in vitro.
Marie PJ; De Vernejoul MC; Lomri A
J Bone Miner Res; 1992 Jan; 7(1):103-13. PubMed ID: 1549953
[TBL] [Abstract][Full Text] [Related]
14. Cell proliferation of human fibroblasts and osteoblasts in osteogenesis imperfecta: influence of age.
Fedarko NS; D'Avis P; Frazier CR; Burrill MJ; Fergusson V; Tayback M; Sponseller PD; Shapiro JR
J Bone Miner Res; 1995 Nov; 10(11):1705-12. PubMed ID: 8592947
[TBL] [Abstract][Full Text] [Related]
15. Long-term extracellular matrix metabolism by cultured human osteogenesis imperfecta osteoblasts.
Fedarko NS; Sponseller PD; Shapiro JR
J Bone Miner Res; 1996 Jun; 11(6):800-5. PubMed ID: 8725177
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical localization of interstitial collagens in bone tissue from patients with various forms of osteogenesis imperfecta.
Nerlich AG; Brenner RE; Wiest I; Lehmann H; Yang C; Müller PK; von der Mark K
Am J Med Genet; 1993 Jan; 45(2):258-9. PubMed ID: 8456813
[TBL] [Abstract][Full Text] [Related]
17. [Osteogenesis imperfecta: contribution to pathobiochemistry].
Pontz BF; Müller PK
Padiatr Padol; 1984; 19(4):365-70. PubMed ID: 6504544
[TBL] [Abstract][Full Text] [Related]
18. Evidence that abnormal high bone mineralization in growing children with osteogenesis imperfecta is not associated with specific collagen mutations.
Roschger P; Fratzl-Zelman N; Misof BM; Glorieux FH; Klaushofer K; Rauch F
Calcif Tissue Int; 2008 Apr; 82(4):263-70. PubMed ID: 18311573
[TBL] [Abstract][Full Text] [Related]
19. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M
APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
[TBL] [Abstract][Full Text] [Related]
20. Osteogenesis imperfecta: changes in noncollagenous proteins in bone.
Vetter U; Fisher LW; Mintz KP; Kopp JB; Tuross N; Termine JD; Robey PG
J Bone Miner Res; 1991 May; 6(5):501-5. PubMed ID: 2068957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
